White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease
3D genome mapping in rare immune cells reveals new Crohn’s disease genes
Elix and University of Vienna agree to use AI to advance drug discovery
KAIST develops way to combat cancer cachexia
Ryght AI and Biorasi to partner on AI
Novel gene therapy for ALS cleared for trials in US and China
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
I-Corps Hub West accelerates deeptech commercialisation in western US